Q3988868 (Q3988868): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Removed claims)
(‎Changed an Item: importing one item from Netherlands)
Property / instance of
 
Property / instance of: Kohesio project / rank
 
Normal rank
Property / financed by
 
Property / financed by: European Union / rank
 
Normal rank
Property / country
 
Property / country: Kingdom of the Netherlands / rank
 
Normal rank
Property / start time
 
1 June 2020
Timestamp+2020-06-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / start time: 1 June 2020 / rank
 
Normal rank
Property / end time
 
1 June 2021
Timestamp+2021-06-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / end time: 1 June 2021 / rank
 
Normal rank
Property / beneficiary name (string)
 
Hercules Pharmaceuticals
Property / beneficiary name (string): Hercules Pharmaceuticals / rank
 
Normal rank
Property / beneficiary
 
Property / beneficiary: Q3985407 / rank
 
Normal rank
Property / EU contribution
 
399,362.0 Euro
Amount399,362.0 Euro
UnitEuro
Property / EU contribution: 399,362.0 Euro / rank
 
Normal rank
Property / budget
 
1,055,117.569 Euro
Amount1,055,117.569 Euro
UnitEuro
Property / budget: 1,055,117.569 Euro / rank
 
Normal rank
Property / co-financing rate
 
37.85 percent
Amount37.85 percent
Unitpercent
Property / co-financing rate: 37.85 percent / rank
 
Normal rank
Property / fund
 
Property / fund: European Regional Development Fund / rank
 
Normal rank
Property / postal code
 
2333BD
Property / postal code: 2333BD / rank
 
Normal rank
Property / programme
 
Property / programme: North Netherlands - ERDF / rank
 
Normal rank
Property / intervention field
 
Property / intervention field: Research and innovation processes in SMEs (including voucher schemes, process, design, service and social innovation) / rank
 
Normal rank

Revision as of 16:05, 13 December 2021

Project Q3988868 in Netherlands
Language Label Description Also known as
English
No label defined
Project Q3988868 in Netherlands

    Statements

    399,362.0 Euro
    0 references
    1,055,117.569 Euro
    0 references
    37.85 percent
    0 references
    1 June 2020
    0 references
    1 June 2021
    0 references
    Hercules Pharmaceuticals
    0 references
    0 references
    2333BD
    0 references

    Identifiers

    OP-2014-2023-Noord-OPSNN0302
    0 references